VNRX Stock Analysis: Why Volitionrx Ltd Scored 50% in Stock Value Finder

Volitionrx Ltd (VNRX): A Detailed Educational Stock Research Review

Overview of Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX) is a healthcare company operating in the medical devices industry. The company focuses on developing blood-based diagnostic tests, primarily for cancer detection. As of this educational review, VNRX trades at a recent price of $0.17 per share. This article provides a detailed, number-driven analysis of VNRX using the StockValueFinder scoring system, which evaluates key financial metrics to help investors understand the company's financial health and valuation discipline.

This is not a recommendation to buy or sell VNRX. Instead, it is an educational breakdown of how StockValueFinder assesses stocks using specific financial metrics. By examining each metric, readers can learn how to evaluate other stocks independently.

Why the StockValueFinder Score Matters

StockValueFinder assigns VNRX a score of 50% and a rating of "AVOID." This score is derived from a systematic evaluation of five core financial tests: EPS strength, ROIC, interest coverage, debt payback, and P/E ratio. Each test is designed to measure a different aspect of financial health, such as profitability, capital efficiency, financial safety, and valuation discipline.

A score of 50% means VNRX passed three out of five tests. While this indicates some financial strengths, it also highlights areas of concern. The "AVOID" rating suggests that the stock does not currently meet StockValueFinder's criteria for a high-quality investment based on the available data. However, this rating is not a prediction of future performance. It is simply a reflection of how VNRX performs against specific financial benchmarks.

EPS Strength and Consistency

What Is EPS?

Earnings per share (EPS) measures a company's profitability on a per-share basis. It is calculated by dividing net income by the number of outstanding shares. EPS consistency is important because it indicates whether a company can generate stable earnings over time. Investors generally prefer companies with predictable, growing EPS, as this suggests a reliable business model.

StockValueFinder's EPS Test

StockValueFinder evaluates EPS strength by examining historical earnings consistency and growth trends. While the exact EPS values for VNRX are not supplied, the system recorded a result of "Did not pass" for this test. This means that VNRX did not meet StockValueFinder's criteria for consistent or improving earnings.

Why EPS Matters

For example, consider two companies

– Company A has reported positive EPS for the last five years, with steady growth each year. – Company B has reported negative EPS for three of the last five years, with erratic swings between profits and losses.

Company A would likely pass the EPS test, while Company B would fail. Consistent earnings suggest a stable business, while erratic earnings may indicate operational or financial challenges.

VNRX's EPS Result

Since VNRX did not pass the EPS test, investors should be cautious about the company's ability to generate consistent profits. This does not mean the company will never become profitable, but it does highlight a potential risk in relying on future earnings stability.

ROIC and Capital Efficiency

What Is ROIC?

Return on invested capital (ROIC) measures how efficiently a company uses its capital to generate profits. It is calculated as: **ROIC = Net Operating Profit After Tax (NOPAT) / Invested Capital**

ROIC is a critical metric because it shows whether a company is generating sufficient returns from the money it invests in its business. A high ROIC suggests that management is deploying capital effectively, while a low ROIC may indicate poor investment decisions or an unprofitable business model.

StockValueFinder's ROIC Benchmark

StockValueFinder generally prefers companies with an ROIC of **10% or higher**. This threshold is based on the idea that a company should generate returns above its cost of capital to create value for shareholders.

VNRX's ROIC

VNRX has an ROIC of **102.53%**, which is exceptionally high. This means the company is generating $1.02 in profit for every $1 of invested capital. While this may seem impressive, it is important to consider why the ROIC is so elevated.

Why ROIC Can Be Misleading

A very high ROIC can sometimes result from

1. **Low Invested Capital**: If a company has minimal capital invested in its operations, even small profits can produce a high ROIC. For example, a company with $1 million in invested capital and $100,000 in NOPAT would have an ROIC of 10%. If the same company had only $100,000 in invested capital, the ROIC would jump to 100%. 2. **Non-Recurring Profits**: One-time gains or accounting adjustments can temporarily inflate ROIC. 3. **Early-Stage Companies**: Startups or companies in high-growth industries may report high ROIC if they are generating strong returns on limited capital.

Given that VNRX is in the medical devices industry, which often requires significant R&D and regulatory investments, the high ROIC may not be sustainable. Investors should investigate whether this ROIC is driven by operational efficiency or other factors, such as low invested capital.

Example of ROIC in Action

Consider two companies

– Company X has an ROIC of 15%. It generates $15 in profit for every $100 of invested capital. – Company Y has an ROIC of 4%. It generates $4 in profit for every $100 of invested capital.

Company X is generally considered more capital-efficient because it generates higher returns on its investments. However, if Company Y operates in a low-margin industry, its ROIC may still be acceptable for its sector.

VNRX's ROIC Result

VNRX passed the ROIC test with a score of 102.53%. While this is a strong result, investors should dig deeper to understand the drivers behind this number. A high ROIC is not inherently bad, but it should be sustainable and aligned with the company's business model.

Interest Coverage and Financial Safety

What Is Interest Coverage?

Interest coverage measures a company's ability to pay the interest on its debt. It is calculated as: **Interest Coverage = Earnings Before Interest and Taxes (EBIT) / Interest Expense**

A higher interest coverage ratio indicates that a company can comfortably meet its interest obligations, while a lower ratio suggests financial strain.

StockValueFinder's Interest Coverage Benchmark

StockValueFinder prefers companies with an interest coverage ratio of **6 or higher**. This threshold ensures that the company has a sufficient buffer to cover interest payments even if earnings decline.

VNRX's Interest Coverage

VNRX did not pass the interest coverage test. While the exact interest coverage ratio is not supplied, the system's "Did not pass" result indicates that VNRX's interest coverage is below the preferred threshold of 6.

Why Interest Coverage Matters

For example

– Company A has an interest coverage ratio of 8. This means it earns $8 for every $1 of interest expense, which is a healthy margin. – Company B has an interest coverage ratio of 2. This means it earns only $2 for every $1 of interest expense, which may be risky if earnings decline.

A low interest coverage ratio can signal financial distress, especially if the company has significant debt. It may also limit the company's ability to borrow additional funds for growth or operations.

VNRX's Interest Coverage Result

Since VNRX did not pass the interest coverage test, investors should be cautious about the company's ability to service its debt. This is particularly important for a company in the medical devices industry, where R&D and regulatory costs can be high.

Debt Payback and Balance Sheet Discipline

What Is Debt Payback?

Debt payback measures how long it would take a company to pay off its debt using its current earnings. It is calculated as: **Debt Payback Years = Total Debt / Annual Free Cash Flow**

A shorter debt payback period indicates a stronger balance sheet, as the company can quickly eliminate its debt burden. A longer debt payback period suggests higher financial risk.

StockValueFinder's Debt Payback Benchmark

StockValueFinder prefers companies with a debt payback period of **3 years or less**. This ensures that the company can manage its debt without overleveraging its balance sheet.

VNRX's Debt Payback

VNRX has a debt payback period of **-0.37 years**. A negative debt payback period typically occurs when a company has **negative free cash flow**, meaning it is not generating enough cash to cover its debt obligations. In such cases, the company may need to rely on external financing or asset sales to meet its debt payments.

Why Debt Payback Matters

For example

– Company X has a debt payback period of 1.5 years. It generates enough free cash flow to pay off its debt in less than two years. – Company Y has a debt payback period of 7 years. It would take much longer to eliminate its debt, which increases financial risk.

A negative debt payback period is a red flag because it indicates that the company is not generating sufficient cash flow to service its debt. This can lead to liquidity issues or even bankruptcy if the situation persists.

VNRX's Debt Payback Result

VNRX passed the debt payback test despite having a negative debt payback period of -0.37 years. This is unusual because a negative debt payback period typically fails the test. However, StockValueFinder's system may have recorded a "pass" due to other factors, such as minimal debt levels or accounting adjustments.

Investors should treat this result with caution. A negative debt payback period is a significant risk, especially for a company in a capital-intensive industry like medical devices.

P/E Ratio and Valuation Discipline

What Is P/E Ratio?

The price-to-earnings (P/E) ratio measures a company's stock price relative to its earnings per share. It is calculated as: **P/E Ratio = Stock Price / Earnings Per Share**

A lower P/E ratio may indicate that a stock is undervalued, while a higher P/E ratio may suggest overvaluation. However, P/E ratios should be interpreted in the context of the company's growth prospects, industry norms, and overall market conditions.

StockValueFinder's P/E Benchmark

StockValueFinder prefers companies with a P/E ratio of **15 or lower**. This threshold is based on the idea that a lower P/E ratio provides a margin of safety for investors, reducing the risk of overpaying for a stock.

VNRX's P/E Ratio

VNRX has a P/E ratio of **-0.07**. A negative P/E ratio occurs when a company reports **negative earnings**. In this case, the P/E ratio is not meaningful in the traditional sense because the company is not profitable.

Why P/E Ratio Matters

For example

– Company A has a P/E ratio of 8. This suggests that investors are paying $8 for every $1 of earnings, which may be attractive if the company's growth prospects are strong. – Company B has a P/E ratio of 40. This suggests that investors are paying $40 for every $1 of earnings, which may be overvalued unless the company is growing rapidly.

A negative P/E ratio is a warning sign because it indicates that the company is not generating profits. While some investors may be willing to pay for growth potential, a negative P/E ratio suggests that the company is not yet financially viable.

VNRX's P/E Ratio Result

VNRX passed the P/E valuation test despite having a negative P/E ratio of -0.07. This is unusual because a negative P/E ratio typically fails the test. However, StockValueFinder's system may have recorded a "pass" due to other factors, such as the company's growth potential or industry dynamics.

Investors should be cautious when interpreting this result. A negative P/E ratio is a significant risk, and it should not be ignored simply because the test was passed.

Moving Average Trend and Entry Timing

What Is a Moving Average?

A moving average is a technical indicator that smooths out price data by calculating the average price over a specific period. It is used to identify trends and potential entry or exit points for a stock.

StockValueFinder's Moving Average Signal

StockValueFinder uses moving averages to assess the trend of a stock. For VNRX, the moving average signal is **"SELL / AVOID TREND."** This suggests that the stock is in a downtrend based on its recent price action.

Why Moving Averages Matter

For example

– If a stock's price is above its 200-day moving average, it may be in an uptrend. – If a stock's price is below its 200-day moving average, it may be in a downtrend.

Moving averages are not foolproof, but they can help investors avoid buying stocks that are in prolonged downtrends.

VNRX's Moving Average Signal

VNRX's "SELL / AVOID TREND" signal indicates that the stock is in a downtrend. This does not mean the stock will continue to decline, but it does suggest that the current trend is unfavorable for buyers.

Entry and Risk Levels

StockValueFinder does not provide specific entry signals, limit buy ideas, pullback zones, or risk/trend levels for VNRX. These metrics are typically used to identify potential buying opportunities or risk management levels, but they are not available for this stock.

Overall Financial Strengths and Weaknesses

Strengths

1. **High ROIC (102.53%)**: VNRX demonstrates exceptional capital efficiency, generating strong returns on its invested capital. However, investors should investigate whether this ROIC is sustainable. 2. **Passed Debt Payback Test**: Despite a negative debt payback period, the system recorded a "pass" for this test. This may indicate minimal debt levels or other mitigating factors. 3. **Passed P/E Valuation Test**: While the P/E ratio is negative, the system recorded a "pass" for this test. This may reflect the company's growth potential or industry dynamics.

Weaknesses

1. **Failed EPS Test**: VNRX did not pass the EPS test, indicating inconsistent or negative earnings. This is a significant risk for investors. 2. **Failed Interest Coverage Test**: The company's interest coverage is below the preferred threshold, suggesting potential financial strain. 3. **Negative Debt Payback Period (-0.37 years)**: A negative debt payback period indicates that VNRX is not generating sufficient free cash flow to service its debt. 4. **Negative P/E Ratio (-0.07)**: A negative P/E ratio signals that the company is not profitable. 5. **"SELL / AVOID TREND" Moving Average Signal**: The stock is in a downtrend, which may not be favorable for buyers.

Risks and Limitations

Financial Risks

1. **Negative Earnings**: VNRX is not profitable, which increases the risk of financial instability. 2. **Negative Free Cash Flow**: The company's negative debt payback period suggests it is not generating enough cash to cover its obligations. 3. **Low Interest Coverage**: The company may struggle to meet its interest payments if earnings decline further. 4. **High ROIC May Not Be Sustainable**: The exceptionally high ROIC may be driven by low invested capital or non-recurring factors, rather than operational efficiency.

Industry Risks

1. **Regulatory Challenges**: The medical devices industry is highly regulated, and VNRX may face delays or rejections in bringing its products to market. 2. **R&D Costs**: Developing diagnostic tests requires significant investment in research and development, which may not always yield profitable products. 3. **Competition**: VNRX operates in a competitive industry, and its success depends on its ability to differentiate its products.

Market Risks

1. **Low Stock Price ($0.17)**: A low stock price can increase volatility and liquidity risk. 2. **Downtrend Signal**: The "SELL / AVOID TREND" moving average signal suggests that the stock may continue to decline in the near term.

Limitations of This Analysis

1. **Incomplete Data**: Some metrics, such as exact EPS values and interest coverage ratios, are not supplied. This limits the depth of the analysis. 2. **No Future Predictions**: This article does not predict future performance or provide investment advice. 3. **Focus on Quantitative Metrics**: The analysis is based on quantitative financial metrics and does not account for qualitative factors, such as management quality or industry trends.

Educational Conclusion

This educational review of Volitionrx Ltd (VNRX) demonstrates how StockValueFinder evaluates stocks using specific financial metrics. By breaking down each metric—EPS strength, ROIC, interest coverage, debt payback, P/E ratio, and moving average trend—investors can learn how to assess other stocks independently.

Key Takeaways

1. **EPS Strength**: VNRX did not pass the EPS test, indicating inconsistent or negative earnings. Investors should prioritize companies with stable, growing earnings. 2. **ROIC**: VNRX passed the ROIC test with a score of 102.53%, but investors should investigate whether this ROIC is sustainable. 3. **Interest Coverage**: VNRX did not pass the interest coverage test, suggesting potential financial strain. 4. **Debt Payback**: VNRX passed the debt payback test despite a negative debt payback period of -0.37 years. This is a red flag, as it indicates the company is not generating sufficient free cash flow. 5. **P/E Ratio**: VNRX passed the P/E valuation test despite a negative P/E ratio of -0.07. This suggests the company is not profitable. 6. **Moving Average Trend**: VNRX's "SELL / AVOID TREND" signal indicates the stock is in a downtrend.

How to Apply This Knowledge

When evaluating other stocks, investors should

– Look for **consistent EPS growth** to ensure profitability. – Prioritize **ROIC of 10% or higher** to assess capital efficiency. – Ensure **interest coverage of 6 or higher** to gauge financial safety. – Aim for **debt payback of 3 years or less** to evaluate balance sheet strength. – Consider **P/E ratios of 15 or lower** for valuation discipline. – Use **moving averages** to identify trends and avoid buying stocks in prolonged downtrends.

Final Thoughts

VNRX has some financial strengths, such as a high ROIC, but it also faces significant risks, including negative earnings, negative free cash flow, and a downtrend signal. The StockValueFinder score of 50% and "AVOID" rating reflect these mixed results.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.

---

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings